poisar

Stocks · News reference

Niki BioSolutions’ DiamiR Biosciences Agrees To Provide Progressive Medical Research With Apolipoprotein E Genotyping Services In Support Of Ongoing Clinical And Translational Research Programs

BenzingaJul 23, 2026, 12:02 PMBenzinga Newsdesk

Partnership Expands Access to Clinically Critical Genetic Testing in Support of Leading Research ProgramsNEW HAVEN, CT and PRINCETON, NJ, July 23, 2026 (GLOBE NEWSWIRE) -- Niki BioSolutions, Inc., a clinical-stage life

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 23, 2026, 12:02 PM
Checked
Jul 23, 2026, 12:02 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading